Signal peptide peptidase and SPP-like proteases - Possible therapeutic targets?
Authors:
- 1 November 2017
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1864 (11) , 2169-2182
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB877, FOR2290)
- SCHR (1284/1-1)
- FL (635/2-1)
This publication has 158 references indexed in Scilit:
- Development of clickable active site-directed photoaffinity probes for γ-secretaseBioorganic & Medicinal Chemistry Letters, 2012
- Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ‐secretase inhibitor targeting notch signalingPediatric Blood & Cancer, 2011
- Plasmodium falciparum signal peptide peptidase is a promising drug target against blood stage malariaBiochemical and Biophysical Research Communications, 2009
- The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cellsCell Death & Differentiation, 2007
- A γ-secretase-like intramembrane cleavage of TNFα by the GxGD aspartyl protease SPPL2bNature Cell Biology, 2006
- SPPL2a and SPPL2b promote intramembrane proteolysis of TNFα in activated dendritic cells to trigger IL-12 productionNature Cell Biology, 2006
- Signal Peptide Peptidase: Biochemical Properties and Modulation by Nonsteroidal Antiinflammatory DrugsBiochemistry, 2006
- Signal peptide peptidase is required for dislocation from the endoplasmic reticulumNature, 2006
- Reconstitution of γ-secretase activityNature Cell Biology, 2003
- L-685,458, an Aspartyl Protease Transition State Mimic, Is a Potent Inhibitor of Amyloid β-Protein Precursor γ-Secretase ActivityBiochemistry, 2000